WAT:NYE-Waters Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 336.79

Change

-12.01 (-3.44)%

Market Cap

USD 10.92B

Volume

0.69M

Analyst Target

USD 210.31
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Waters Corp is an analytical instrument manufacturer. It designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
TMO Thermo Fisher Scientific Inc

N/A

USD 219.83B
DHR Danaher Corporation

N/A

USD 191.36B
IQV IQVIA Holdings Inc

N/A

USD 39.94B
A Agilent Technologies Inc

N/A

USD 37.89B
MTD Mettler-Toledo International I..

N/A

USD 30.86B
LH Laboratory Corporation of Amer..

N/A

USD 16.74B
DGX Quest Diagnostics Incorporated

N/A

USD 15.68B
RVTY Revvity Inc.

N/A

USD 13.69B
CRL Charles River Laboratories

N/A

USD 10.94B
QGEN Qiagen NV

N/A

USD 9.95B

ETFs Containing WAT

FIW First Trust Water ETF 3.48 % 0.55 %

N/A

USD 1.71B
XLVE:CA Mulvihill U.S. Health Car.. 1.81 % 0.00 %

N/A

CAD 7.08M
PIO Invesco Global Water ETF 0.00 % 0.75 %

N/A

USD 0.28B
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

N/A

CAD 0.05B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.30% 50% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.30% 43% F 43% F
Trailing 12 Months  
Capital Gain 29.75% 100% F 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.75% 100% F 78% C+
Trailing 5 Years  
Capital Gain 63.29% 45% F 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 63.29% 45% F 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.27% 54% F 75% C
Dividend Return 12.27% 54% F 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 32.64% 23% F 33% F
Risk Adjusted Return 37.58% 46% F 59% D-
Market Capitalization 10.92B 62% D 90% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.60 67% 19%
Price/Book Ratio 16.64 23% 4%
Price / Cash Flow Ratio 35.03 15% 7%
Price/Free Cash Flow Ratio 21.16 46% 13%
Management Effectiveness  
Return on Equity 65.02% 100% 98%
Return on Invested Capital 25.68% 86% 92%
Return on Assets 13.22% 92% 96%
Debt to Equity Ratio 200.42% 15% 17%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector